{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:54:30Z","timestamp":1795056870231,"version":"4.10.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neuropharm.2023.109424","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T02:06:50Z","timestamp":1674871610000},"page":"109424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7105-1927","authenticated-orcid":false,"given":"Laura B.","family":"Teal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109424_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2006.07.010","article-title":"Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice","volume":"24","author":"Araya","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109424_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00406-019-01052-7","article-title":"Impaired working memory performance in opioid-dependent patients is related to reduced insula gray matter volume: a voxel-based morphometric study","volume":"271","author":"Bach","year":"2021","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109424_bib3","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1073\/pnas.162371899","article-title":"Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia","volume":"99","author":"Basile","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2023.109424_bib4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41386-017-0007-3","article-title":"Muscarinic M5 receptors modulate ethanol seeking in rats","volume":"43","author":"Berizzi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109424_bib5","article-title":"A comparison of the alpha-2-adrenergic receptor agonists for managing opioid withdrawal","volume":"20","author":"Crumb","year":"2020","journal-title":"Pract Pain Manag"},{"key":"10.1016\/j.neuropharm.2023.109424_bib6","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1523\/JNEUROSCI.4896-13.2014","article-title":"M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location","volume":"34","author":"Foster","year":"2014","journal-title":"J. Neurosci."},{"issue":"3 42","key":"10.1016\/j.neuropharm.2023.109424_bib7","first-page":"671","article-title":"Reciprocal catecholamine changes during opiate exposure and withdrawal","volume":"42","author":"Fox","year":"2016","journal-title":"Neuropsychopharmacology 2017"},{"key":"10.1016\/j.neuropharm.2023.109424_bib8","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1021\/jm4013246","article-title":"Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1 H -imidazo[2,1- a ]isoindol-5(9b H)-one (ML375)","volume":"56","author":"Gentry","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2023.109424_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuropharm.2017.07.013","article-title":"Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M4 PAM VU0467154","volume":"128","author":"Gould","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109424_bib10","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1021\/acschemneuro.9b00274","article-title":"Acute negative allosteric modulation of M5 muscarinic acetylcholine receptors inhibits oxycodone self-administration and cue-induced reactivity with No effect on antinociception","volume":"10","author":"Gould","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109424_bib11","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2023.109424_bib12","article-title":"Selective inhibition of M5 muscarinic acetylcholine receptors attenuates cocaine self-administration in rats","volume":"23","author":"Gunter","year":"2017","journal-title":"Addiction Biol."},{"issue":"3 13","key":"10.1016\/j.neuropharm.2023.109424_bib13","first-page":"222","article-title":"Comprehensive observational assessment: ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia 1968"},{"key":"10.1016\/j.neuropharm.2023.109424_bib14","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1523\/JNEUROSCI.1850-08.2008","article-title":"Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats","volume":"28","author":"Jones","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109424_bib15","series-title":"Mirtazapine, a Noradrenergic and Specific Serotonergic Antidepressant, Attenuates Morphine Dependence and Withdrawal in Sprague-Dawley Rats","first-page":"541","author":"Kang","year":"2009"},{"key":"10.1016\/j.neuropharm.2023.109424_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1037\/0735-7044.118.1.97","article-title":"Hippocampus and pavlovian fear conditioning in rats: muscimol infusions into the ventral, but not dorsal, Hippocampus impair the acquisition of conditional freezing to an auditory conditional stimulus","volume":"118","author":"Maren","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109424_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bmcl.2017.02.020","article-title":"Continued optimization of the M5 NAM ML375: Discovery of VU6008667, an M5 NAM with high CNS penetration and a desired short half-life in rat for addiction studies","volume":"27","author":"McGowan","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2023.109424_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.physbeh.2007.01.011","article-title":"Central opioids and consumption of sweet tastants: when reward outweighs homeostasis","volume":"91","author":"Olszewski","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2023.109424_bib19","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1424-21.2022","article-title":"Chronic loss of muscarinic M5 receptor function manifests disparate impairments in exploratory behavior in male and female mice despite common dopamine regulation","author":"Razidlo","year":"2022","journal-title":"Journal of Neuroscience JN-"},{"key":"10.1016\/j.neuropharm.2023.109424_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2023.109424_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use \u2014 United States, 2006\u20132015","volume":"66","author":"Shah","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neuropharm.2023.109424_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109424_bib23","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1073\/pnas.1508846112","article-title":"Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens","volume":"112","author":"Shin","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2023.109424_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2017.09.022","article-title":"Opioid-induced rewards, locomotion, and dopamine activation: a proposed model for control by mesopontine and rostromedial tegmental neurons","volume":"83","author":"Steidl","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2023.109424_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/jpet.108.144824","article-title":"M5 muscarinic receptor knockout mice show reduced morphine-induced locomotion but increased locomotion after cholinergic antagonism in the ventral tegmental area","volume":"328","author":"Steidl","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109424_bib26","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1523\/JNEUROSCI.2077-05.2005","article-title":"Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice","volume":"25","author":"Thomsen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109424_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(75)90208-3","article-title":"Effects of clonidine on morphine withdrawal signs in the rat","volume":"30","author":"Tseng","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109424_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02245935","article-title":"Comparison of 7 nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal","volume":"118","author":"Vaupel","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109424_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0304-3940(90)90064-G","article-title":"Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry","volume":"114","author":"Vilar\u00f3","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109424_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109424_bib31","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/sj.npp.1300502","article-title":"Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region","volume":"29","author":"Wang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109424_bib32","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","article-title":"Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia","volume":"87","author":"Weiner","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2023.109424_bib33","doi-asserted-by":"crossref","first-page":"14096","DOI":"10.1073\/pnas.251542998","article-title":"Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice","volume":"98","author":"Yamada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2023.109424_bib34","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41386-018-0284-5","article-title":"Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects","volume":"44","author":"You","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109424_bib35","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082300014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082300014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:21:20Z","timestamp":1758439280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082300014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"alternative-id":["S002839082300014X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109424","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109424"}}